June 05, 2013
A New Jersey federal judge said Tuesday that Braintree Laboratories Inc.'s patent on Suprep is valid, a ruling that follows the judge's finding in January that Novel Laboratories Inc.'s plan to make a generic version of the colon cleanser infringed the patent.
January 22, 2013
A New Jersey federal judge ruled Friday that Novel Laboratories Inc., a company that planned to make a generic of the colon-cleansing drug Suprep, infringed Braintree Laboratories Inc.'s patent on the branded version of the medication.